Weight Loss with EGPA (Churg-Strauss) in South Africa

Weight Loss with EGPA Churg-Strauss Syndrome South Africa

Eosinophilic granulomatosis with polyangiitis — EGPA, or by its former name, Churg-Strauss syndrome — is a rare systemic vasculitis with a distinctive clinical story. It almost always begins years before the vasculitis becomes apparent, hiding in plain sight as severe, late-onset asthma that seems unusually difficult to control, accompanied by allergic rhinitis, nasal polyps, and sinusitis. Then, sometimes abruptly, the vasculitic phase emerges — and the condition's true nature becomes clear.

What makes EGPA particularly challenging for weight management is the combination of severe chronic respiratory disease (limiting exercise capacity), the risk of eosinophilic heart damage (the most dangerous manifestation, which constrains physical exertion), prolonged high-dose corticosteroid exposure (driving weight gain and muscle wasting), and systemic inflammatory catabolism during active vasculitis.

This guide maps out how to navigate nutrition and weight management safely with EGPA in a South African context.

This article is for informational purposes only. All dietary and exercise decisions in EGPA must be made in consultation with your rheumatologist, pulmonologist, and cardiologist.

Understanding EGPA: The Three-Phase Story

EGPA unfolds in a characteristic three-phase progression, though not every patient moves through all phases sequentially:

Phase 1: Prodromal (Years to Decades)

Phase 2: Eosinophilic

Phase 3: Vasculitic

EGPA and Weight: The Challenge of Multiple Directions

Weight management in EGPA is complicated by several overlapping factors:

Vasculitic Wasting

During the active vasculitic phase — particularly with fever, systemic inflammation, and severe fatigue — patients often lose weight involuntarily. The cytokine storm (TNF-alpha, IL-5, IL-6) drives inflammatory catabolism, appetite suppression, and increased resting energy expenditure. Maintaining calorie and protein intake during this phase is the priority.

Respiratory Limitation

Severe asthma and eosinophilic lung disease significantly limit exercise capacity, which reduces calorie expenditure and makes weight management harder. Breathlessness on exertion is a real barrier to the physical activity that would otherwise support healthy weight.

Cardiac Involvement

Eosinophilic cardiomyopathy, when present, reduces cardiac output and can cause heart failure symptoms including fluid retention and leg oedema — which may superficially appear as weight gain while actually representing pathological fluid accumulation rather than fat.

Gastrointestinal Involvement

Eosinophilic infiltration of the gut can cause malabsorption, diarrhoea, and significant abdominal pain that impairs eating — contributing to involuntary weight loss during active gastrointestinal disease.

Corticosteroid Effects

High-dose prednisolone (often 1 mg/kg/day) is the cornerstone of EGPA treatment — and prolonged high-dose steroid use drives the characteristic Cushingoid changes: central fat deposition, moon face, buffalo hump, fluid retention, insulin resistance, and muscle wasting in the limbs. This is the most common reason EGPA patients gain weight during treatment despite the inflammatory wasting of active disease.

Asthma-Safe Eating with EGPA

The severe asthma in EGPA's prodromal and ongoing phases means food trigger awareness is important. Key dietary considerations for EGPA-associated asthma:

Sulphites: The Hidden Asthma Trigger in SA Food

Sulphites (E220–E228) are added as preservatives to many foods and are a well-documented asthma trigger for sensitive individuals. In South Africa, sulphite-containing foods to be cautious about include:

Read ingredient labels and look for E220 (sulphur dioxide), E221 (sodium sulphite), E222 (sodium bisulphite), E223 (sodium metabisulphite), E224 (potassium metabisulphite) — any of these should be treated with caution.

Aspirin-Exacerbated Respiratory Disease (AERD)

Up to 30% of patients with severe asthma and nasal polyps — a profile that fits many EGPA patients — have AERD, also called Samter's triad (asthma + nasal polyps + NSAID sensitivity). If you have AERD:

Other Common Asthma Trigger Foods

Nutritional Strategy During Active Vasculitis

During active EGPA vasculitic disease — fever, weight loss, severe fatigue — the goal is preventing dangerous wasting while supporting the immune response:

Managing Corticosteroid Weight Gain in EGPA

EGPA often requires some of the highest and longest steroid courses of any inflammatory condition — 1 mg/kg/day for several weeks, then a slow taper over months. Strategies to minimise weight gain:

Anti-Inflammatory Diet Choices for EGPA

A Mediterranean anti-inflammatory diet is well aligned with EGPA management:

Exercise with EGPA: Safety First

Exercise with EGPA requires careful cardiac and pulmonary clearance before any programme is started:

Cardiac Clearance is Non-Negotiable

Eosinophilic cardiomyopathy is the leading cause of death in EGPA. Any patient with a history of cardiac involvement must have:

Asthma-Safe Exercise

Exercise During Remission

Treatment Costs in South Africa

EGPA is listed as a PMB vasculitis condition. All South African medical aid schemes must fund treatment to PMB standards. Work with your rheumatologist to ensure proper coding and pre-authorisation, particularly for biologics like mepolizumab.

SA Resources and Support

Related Reading

EGPA Demands a Team — Your Nutrition Plan Should Too

Between the asthma, potential cardiac involvement, vasculitic wasting, prolonged high-dose corticosteroid treatment, and the dietary restrictions needed for asthma trigger avoidance, EGPA is one of the most complex conditions for nutritional management. A registered dietitian working alongside your rheumatologist, pulmonologist, and cardiologist can build a practical, SA-context eating plan that keeps you well-nourished through active disease, manages steroid-driven weight gain during treatment, and helps you rebuild during remission — all while keeping your airways and heart protected.